Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Interest Coverage Ratio: 2022-2025

Historic Interest Coverage Ratio for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to -2,268.27.

  • Taysha Gene Therapies' Interest Coverage Ratio fell 110.20% to -2,268.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -1,399.04, marking a year-over-year decrease of 1163.99%. This contributed to the annual value of -896.66 for FY2024, which is 6086.57% down from last year.
  • According to the latest figures from Q3 2025, Taysha Gene Therapies' Interest Coverage Ratio is -2,268.27, which was down 44.14% from -1,573.71 recorded in Q2 2025.
  • Taysha Gene Therapies' 5-year Interest Coverage Ratio high stood at -11.05 for Q3 2023, and its period low was -2,268.27 during Q3 2025.
  • Over the past 3 years, Taysha Gene Therapies' median Interest Coverage Ratio value was -838.97 (recorded in 2024), while the average stood at -785.86.
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first soared by 83.69% in 2023, then slumped by 9,668.19% in 2024.
  • Taysha Gene Therapies' Interest Coverage Ratio (Quarterly) stood at -41.35 in 2022, then surged by 44.90% to -22.79 in 2023, then tumbled by 3,876.23% to -906.00 in 2024, then slumped by 110.20% to -2,268.27 in 2025.
  • Its Interest Coverage Ratio was -2,268.27 in Q3 2025, compared to -1,573.71 in Q2 2025 and -1,127.42 in Q1 2025.